Plasma phosphorylated tau and neuropsychiatric symptoms in dementia with Lewy bodies

by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia

Abstract INTRODUCTION Neuropsychiatric symptoms (NPSs) are common in dementia with Lewy bodies (DLB) but their neurobiological mechanisms are poorly understood. METHODS NPSs and cognition were assessed annually in participants (DLB n = 222; Alzheimer’s disease...

Disrupted brain networks underlying high‐fidelity memory retrieval in subjective cognitive decline: A task‐based fMRI study

by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia

Abstract INTRODUCTION Subjective cognitive decline (SCD) is linked to memory complaints and disruptions in certain brain regions identified by molecular imaging and resting-state functional magnetic resonance imaging studies. However, it remains unclear how these...

Precision diagnosis of cognitive impairment due to Alzheimer’s disease for therapeutic interventions

by Clinical Neuropsychologist | Tuesday, December 24, 2024 | Dementia

Abstract With the advent of anti-amyloid monoclonal antibody (AAMA) therapy, precision diagnosis is necessary for identifying appropriate patients with cognitive disorders due to Alzheimer’s disease. Therapy with AAMAs requires that candidates be diagnosed with...

Correction to Prevalent stroke, age of its onset, and post‐stroke lifestyle in relation to dementia: A prospective cohort study

by Clinical Neuropsychologist | Tuesday, December 24, 2024 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | December 24, 2024 Wiley: Alzheimer’s & Dementia:...

Alzheimer’s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer’s Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for primary care

by Clinical Neuropsychologist | Monday, December 23, 2024 | Dementia

Abstract US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer’s disease (AD) or AD and related dementias (ADRD) are decades old and aimed at specialists. This evidence-based guideline was developed to empower...

The Alzheimer’s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer’s Disease and Related Disorders (DETeCD‐ADRD): Executive summary of recommendations for specialty care

by Clinical Neuropsychologist | Monday, December 23, 2024 | Dementia

Abstract US clinical practice guidelines for the diagnostic evaluation of cognitive impairment due to Alzheimer’s disease (AD) or a related dementia (ADRD) are two decades old. This evidence-based guideline was developed to empower all clinicians to implement a...